|
Designated Public Office Holders who participated in the communication:
|
Greg Orencsak,
Deputy Minister of Health
Health Canada (HC)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health
|
Health Care reform as it relates to affordable access to prescription drugs, and high cost drugs for rare disease strategy. Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals as an association.
|
|
| |
|
Responsible Officer who filed this communication report:
|
Stephen Frank
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
